721 related articles for article (PubMed ID: 10961047)
1. [Huntington disease. A review].
Bonilla E
Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
[TBL] [Abstract][Full Text] [Related]
2. Selective neuronal degeneration in Huntington's disease.
Cowan CM; Raymond LA
Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects of Huntington's disease.
Walling HW; Baldassare JJ; Westfall TC
J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
[TBL] [Abstract][Full Text] [Related]
4. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
[TBL] [Abstract][Full Text] [Related]
5. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
6. The early cellular pathology of Huntington's disease.
Li XJ
Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117
[TBL] [Abstract][Full Text] [Related]
7. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
[TBL] [Abstract][Full Text] [Related]
8. Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM; Warby SC; Hayden MR
Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
[TBL] [Abstract][Full Text] [Related]
9. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals.
Landwehrmeyer GB; McNeil SM; Dure LS; Ge P; Aizawa H; Huang Q; Ambrose CM; Duyao MP; Bird ED; Bonilla E
Ann Neurol; 1995 Feb; 37(2):218-30. PubMed ID: 7847863
[TBL] [Abstract][Full Text] [Related]
10. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of copper ion mediated Huntington's disease progression.
Fox JH; Kama JA; Lieberman G; Chopra R; Dorsey K; Chopra V; Volitakis I; Cherny RA; Bush AI; Hersch S
PLoS One; 2007 Mar; 2(3):e334. PubMed ID: 17396163
[TBL] [Abstract][Full Text] [Related]
12. Huntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease.
Roze E; Bonnet C; Betuing S; Caboche J
Adv Exp Med Biol; 2010; 685():45-63. PubMed ID: 20687494
[TBL] [Abstract][Full Text] [Related]
14. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
16. Are there multiple pathways in the pathogenesis of Huntington's disease?
Aronin N; Kim M; Laforet G; DiFiglia M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):995-1003. PubMed ID: 10434298
[TBL] [Abstract][Full Text] [Related]
17. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
Singhrao SK; Thomas P; Wood JD; MacMillan JC; Neal JW; Harper PS; Jones AL
Exp Neurol; 1998 Apr; 150(2):213-22. PubMed ID: 9527890
[TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
19. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
[TBL] [Abstract][Full Text] [Related]
20. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
